- Details
- Description
Packaging Size:
30 tablets in an HDPE container
Strength:
15 mg
Composition:
Upadacitinib INN 15 mg per extended-release film-coated tablet
Treatment:
JAK inhibitor used for rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and polyarticular juvenile idiopathic arthritis, according to the applicable indication
Form:
Extended-release film-coated tablet
Brand:
Upajak 15 mg
Quantity Unit:
Tablet
Manufacturer:
Everest Pharmaceuticals Ltd., Bangladesh
Upajak 15 mg Tablet (Upadacitinib INN 15 mg) is an oral Janus kinase (JAK) inhibitor used to reduce abnormal immune-system activity and inflammation. It is indicated for several chronic inflammatory and autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn’s disease, ankylosing spondylitis, and non-radiographic axial spondyloarthritis, depending on the patient’s age and clinical condition. Upajak contains upadacitinib 15 mg in an extended-release film-coated tablet and is manufactured by Everest Pharmaceuticals Ltd.
